Medicated-Assisted Treatment in Indiana

Simple item page
dc.contributor.authorKooreman, Harold
dc.date.accessioned2020-03-05T15:51:56Z
dc.date.available2020-03-05T15:51:56Z
dc.date.issued2019-03-01
dc.description.abstractOpioid misuse and addiction continues to affect many Americans. Medication-assisted treatment (MAT) using methadone, buprenorphine, or extended-release naltrexone in combination with behavioral therapy is the most effective intervention for opioid use disorders (OUDs). Despite its effectiveness, methadone to treat OUDs is not widely available. Buprenorphine is more accessible, as it can be prescribed by medical doctors, nurse practitioners, and physician assistants who have received specialized training and obtained a waiver from the DEA. Naltrexone is a non-narcotic and can be prescribed by any healthcare professional who has prescription privileges.en_US
dc.identifier.citationKooreman, H. (2019). "Medication-Assisted Treatment in Indiana". Published by The Center for Health Policy at the IU Richard M. Fairbanks School of Public Health, Indianapolis, IN.en_US
dc.identifier.urihttps://hdl.handle.net/1805/22251
dc.publisherThe Center for Health Policy
dc.relation.ispartofseries19-H03;
dc.subjectMedication-Assisted Treatmenten_US
dc.subjectOpioid Use Disorderen_US
dc.subjectBuprenorphineen_US
dc.subjectSubstance Useen_US
dc.subjectPrescriptionen_US
dc.titleMedicated-Assisted Treatment in Indianaen_US
dc.typeOtheren_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Medicated-Assisted Treatment in Indiana.pdf
Size:
1.74 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Center for Health Policy, IU Richard M. Fairbanks School of Public Health